FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065856498> ?p ?o ?g. }

• W2065856498 endingPage "2231" @default.
• W2065856498 startingPage "2226" @default.
• W2065856498 abstract "An increased prevalence of elevated serum anti-Saccharomyces cerevisiae antibody (ASCA) levels in patients with Crohn's disease (CD) has been described. The aim of the present work was to investigate serum ASCA levels during the courses of prednisolone and mesalamine therapy in CD patients.Serum samples of 25 patients with active CD were studied for ASCA levels before as well as 2 and 9 wk after initiation of a prednisolone tapering regimen. The influence of mesalamine (4 g o.d.) on serum ASCA levels compared to that of placebo was tested over 1 yr in 38 patients (20 mesalamine and 18 placebo) participating in a postoperative prophylaxis study. Serum IgG and IgA ASCA levels were measured by ELISA. Sera of 91 CD and 40 ulcerative colitis (UC) patients as well as 334 healthy donors were tested for ASCA to recalculate new cut-off values.For IgG ASCA cut-off values were determined to be 17.0 U and 25.0 U, and for IgA ASCA 9.3 U and 14.0 U. At baseline visit, 73.0% (46/63) of patients displayed serum ASCA positivity. During prednisolone therapy, a decrease in serum IgG and IgA ASCA levels from baseline to wk 2 (p < 0.0001 and p < 0.001, respectively) as well as to wk 9 (p < 0.001 and p = 0.01, respectively) was observed. A trend toward an association of ASCA positivity and steroid responsiveness was calculated (p = 0.07). During mesalamine treatment, no differences in changes of ASCA levels were observed compared to placebo at any time point.ASCA are stable markers during steroid and mesalamine treatment, highlighting their reliability for use in diagnosis of CD." @default.
• W2065856498 created "2016-06-24" @default.
• W2065856498 creator A5013058329 @default.
• W2065856498 creator A5015714294 @default.
• W2065856498 creator A5018852965 @default.
• W2065856498 creator A5047076878 @default.
• W2065856498 creator A5060323357 @default.
• W2065856498 creator A5065325813 @default.
• W2065856498 creator A5071510920 @default.
• W2065856498 creator A5074942131 @default.
• W2065856498 date "2003-10-01" @default.
• W2065856498 modified "2023-09-30" @default.
• W2065856498 title "Anti- Saccharomyces Cerevisiae Antibodies: A Stable Marker for Crohn's Disease During Steroid and 5-Aminosalicylic Acid Treatment" @default.
• W2065856498 cites W1482124206 @default.
• W2065856498 cites W1573810982 @default.
• W2065856498 cites W1737578516 @default.
• W2065856498 cites W1761355724 @default.
• W2065856498 cites W1805232197 @default.
• W2065856498 cites W1968783088 @default.
• W2065856498 cites W1969584481 @default.
• W2065856498 cites W1975204619 @default.
• W2065856498 cites W2006184446 @default.
• W2065856498 cites W2015763539 @default.
• W2065856498 cites W2020953325 @default.
• W2065856498 cites W2030033188 @default.
• W2065856498 cites W2030538375 @default.
• W2065856498 cites W2035742267 @default.
• W2065856498 cites W2041191366 @default.
• W2065856498 cites W2048981133 @default.
• W2065856498 cites W2050518038 @default.
• W2065856498 cites W2051969645 @default.
• W2065856498 cites W2053232923 @default.
• W2065856498 cites W2058930138 @default.
• W2065856498 cites W2061095489 @default.
• W2065856498 cites W2098638622 @default.
• W2065856498 cites W2100028493 @default.
• W2065856498 cites W2110258255 @default.
• W2065856498 cites W2112102793 @default.
• W2065856498 cites W2112449462 @default.
• W2065856498 cites W2119817537 @default.
• W2065856498 cites W2122247171 @default.
• W2065856498 cites W2128466852 @default.
• W2065856498 cites W2139367245 @default.
• W2065856498 cites W2152037982 @default.
• W2065856498 cites W2154117979 @default.
• W2065856498 cites W2171655564 @default.
• W2065856498 cites W2404854108 @default.
• W2065856498 cites W3149527659 @default.
• W2065856498 cites W41633534 @default.
• W2065856498 doi "https://doi.org/10.1111/j.1572-0241.2003.07673.x" @default.
• W2065856498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14572572" @default.
• W2065856498 hasPublicationYear "2003" @default.
• W2065856498 type Work @default.
• W2065856498 sameAs 2065856498 @default.
• W2065856498 citedByCount "59" @default.
• W2065856498 countsByYear W20658564982012 @default.
• W2065856498 countsByYear W20658564982013 @default.
• W2065856498 countsByYear W20658564982015 @default.
• W2065856498 countsByYear W20658564982016 @default.
• W2065856498 countsByYear W20658564982017 @default.
• W2065856498 countsByYear W20658564982018 @default.
• W2065856498 countsByYear W20658564982019 @default.
• W2065856498 countsByYear W20658564982020 @default.
• W2065856498 countsByYear W20658564982021 @default.
• W2065856498 countsByYear W20658564982022 @default.
• W2065856498 crossrefType "journal-article" @default.
• W2065856498 hasAuthorship W2065856498A5013058329 @default.
• W2065856498 hasAuthorship W2065856498A5015714294 @default.
• W2065856498 hasAuthorship W2065856498A5018852965 @default.
• W2065856498 hasAuthorship W2065856498A5047076878 @default.
• W2065856498 hasAuthorship W2065856498A5060323357 @default.
• W2065856498 hasAuthorship W2065856498A5065325813 @default.
• W2065856498 hasAuthorship W2065856498A5071510920 @default.
• W2065856498 hasAuthorship W2065856498A5074942131 @default.
• W2065856498 hasConcept C126322002 @default.
• W2065856498 hasConcept C142724271 @default.
• W2065856498 hasConcept C159654299 @default.
• W2065856498 hasConcept C203014093 @default.
• W2065856498 hasConcept C204787440 @default.
• W2065856498 hasConcept C27081682 @default.
• W2065856498 hasConcept C2776715498 @default.
• W2065856498 hasConcept C2776804153 @default.
• W2065856498 hasConcept C2779134260 @default.
• W2065856498 hasConcept C2780479503 @default.
• W2065856498 hasConcept C71924100 @default.
• W2065856498 hasConcept C90924648 @default.
• W2065856498 hasConceptScore W2065856498C126322002 @default.
• W2065856498 hasConceptScore W2065856498C142724271 @default.
• W2065856498 hasConceptScore W2065856498C159654299 @default.
• W2065856498 hasConceptScore W2065856498C203014093 @default.
• W2065856498 hasConceptScore W2065856498C204787440 @default.
• W2065856498 hasConceptScore W2065856498C27081682 @default.
• W2065856498 hasConceptScore W2065856498C2776715498 @default.
• W2065856498 hasConceptScore W2065856498C2776804153 @default.
• W2065856498 hasConceptScore W2065856498C2779134260 @default.
• W2065856498 hasConceptScore W2065856498C2780479503 @default.
• W2065856498 hasConceptScore W2065856498C71924100 @default.
• W2065856498 hasConceptScore W2065856498C90924648 @default.

• next